• Curaleaf Holdings (CURA) has been granted final approval to open its adult-use dispensary in Ware, Massachusetts
  • The approval marks the company’s third adult-use location in the state, with locations already operational in Oxford and Princetown
  • Curaleaf is the largest cannabis company in the US in terms of operational capacity, with 53 dispensaries across the country
  • Shares in the company are currently down 1.77 per cent to C$8.87, with a market cap of C$4.17 billion

Curaleaf Holdings (CURA) has been granted final license approval for its adult-use retail dispensary in Ware, Massachusetts.

The approval marks the company’s third Massachusetts-based adult-use location, with existing dispensaries in Oxford and Princetown.

“Providing high quality and reliable products to patients and customers in our home state of Massachusetts is a big part of our company’s strategy,” said Curaleaf CEO, Joseph Lusardi. 

“We’re excited to be opening our third adult-use dispensary here in the Commonwealth of Massachusetts.”

Headquartered in Wakefield, Curaleaf is the largest cannabis operator in the United States in terms of operational and wholesale footprint, with 53 dispensaries currently active nation-wide.

“We will be adding more than twenty new jobs to the local economy and we look forward to building an impactful, positive relationship with the community,” said Curaleaf Massachusetts President, Patrik Jonsson.

“We feel very honored to be bringing our business to Ware, located in the Hampshire County and the greater Springfield area.”

Earlier this month, Curaleaf announced the acquisition of Cura Partners Inc., owner of the popular Select brand, in a deal that “marks an unprecedented phase of growth for our company,” Mr. Lusardi said at the time.

Curaleaf shares are currently down 1.77 per cent to C$8.87, with a market cap of C$4.17 billion.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.